Patrick Aebischer completed his training in Medicine (1980) and Neuroscience (1983) at the Universities of Geneva and Friborg in Switzerland. From 1984 to 1992 Patrick Aebischer worked at Brown University (USA) in the Department of Neurosciences and in the Department of Biomaterials and Artificial Bodies as Assistant Professor and Associate Professor. In 1992, Patrick Aebischer was appointed Professor of the Autonomous Division of Surgical Research and of the Center for Therapeutic Therapy (DARC) at the Center Hospitalier Universitaire Vaudois (CHUV) in Lausanne.In 1999, the Federal Council appointed Patrick Aebischer as President of the Swiss Federal Institute of Technology in Lausanne (EPFL). He took office at the EPFL Presidency in March 2000, a position he held until 31 December 2016. Patrick Aebischer is a member of many professional societies, both in Europe and in the United States. Patrick Aebischer founded three biotechnology start-ups. He sits on the board of directors of Lonza, Logitech and Nestlé. He also chairs the advisory board of the Novartis Venture Fund. Patrick Aebischer is a member of the Foundation Board of the Montreux Jazz Festival, the Verbier Festival and the Jacobs Foundation.His current research in his laboratory focuses on the development of cell therapy and gene transfer approaches for the treatment of neurodegenerative diseases. 

   neuroscience